×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
华中师范大学 [2]
武汉大学 [1]
内容类型
期刊论文 [3]
发表日期
2018 [1]
2015 [1]
2014 [1]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共3条,第1-3条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Increased expression of G9A contributes to carcinogenesis and indicates poor prognosis in hepatocellular carcinoma
期刊论文
ONCOLOGY LETTERS, 2018, 卷号: 15, 期号: 6
作者:
Qin, Jian
;
Li, Qingyun
;
Zeng, Zhi
;
Wu, Ping
;
Jiang, Yanping
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/05
euchromatic histone-lysine N-methyltransferase
proliferation
prognosis
LC3B
hepatocellular carcinoma
Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation
期刊论文
Pharmacology and Therapeutics, 2015, 卷号: 151, 页码: 121-140
作者:
Liu, Ke
;
Liu, Yanli
;
Lau, Johnathan L
;
Min, Jinrong*
收藏
  |  
浏览/下载:13/0
  |  
提交时间:2019/12/23
Histone demethylation
DNA methylation
Inhibitor
Chemical probe
Drug discovery
LSD
lysine-specific histone demethylase
HDAC
histone deacetylase
REST
REST corepressor
DNMT
DNA methyltransferase
MAO
monoamine oxidase
AML
acute myeloid leukemia
KDM
lysine-specific demethylase
MLL
mixed lineage leukemia
FAD
flavin adenine dinucleotide
PCPA
trans-2-phenylcyclopropylamine
2,4-PDCA
2, 4-pyridinedicarboxylic acid
PHD
plant homeobox domain
SCLC
small cell lung cancer
JHDMs
JmjC-domain-containing histone demethylases
NOG
N-oxalylglycine
IOX1
5-carboxy-8-hydroxyquinoline
MDS
myelodysplastic syndrome
2-OG, 2-oxoglutarate or
α-ketoglutarate
G9a
euchromatic histone-lysine N-methyltransferase 2
CoREST complex
restin corepressor complex
SAH
S-adenosyl-l-homocysteine
l
SWI complex
ATP dependent chromatin remodeling complexes
Pan-Histone Demethylase Inhibitor
the inhibitor can simultaneously inhibit both LSDs and JHDMs
LSC colony
leukemic stem cell colony
Pan JmjC domain-containing demethylase inhibitor
the inhibitor can simultaneously inhibit all the members of JHDMs
E2F1
E2F transcription factor 1
E2F2
E2F transcription factor 2
RCC
renal cell carcinoma
Epigenetic targets and drug discovery: Part 1: Histone methylation
期刊论文
Pharmacology and Therapeutics, 2014, 卷号: 143, 期号: 3, 页码: 275-294
作者:
Liu, Yanli
;
Liu, Ke
;
Qin, Su
;
Xu, Chao
;
Min, Jinrong*
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/23
Epigenetics
Histone methylation
Inhibitor
Chemical probe
Cancer
PTM
posttranslational modification
HMTs
histone methyltrans-ferases
SET
Suv39, E(z) and Trithorax
SUV39
Su(var)3-9
SUV420
histone-lysine N-methyltransferase SUV420
G9a
euchromatic histone-lysine N-methyltransferase 2
GLP
G9a-like protein 1
Wiz
widely-interspaced zinc finger-containing protein
CDYL1
chromodomain Y-like protein
ACIN1
apoptotic chromatin condensation inducer in the nucleus
SAH
S-adenosyl-l-homocysteine
l
SAM
S-adenosylmethionine
Dot1
disruptor of telomeric silencing
Dot1L
DOT1-Like protein
EZH1
Enhancer of zeste homolog 1
EZH2
Enhancer of zeste homolog 2
Hox
homeotic box
PcG
Polycomb group
PRC1
Polycomb Repressive Complex 1
PRC2
Polycomb Repressive Complex 2
DZNep
3-Deazan- eplanocin A
SMYD2
SET and MYND domain-containing protein 2
PRMT
protein arginine methyltransferases
AMI-1
arginine methyltransferase inhibitor-1
MBT
Malignant Brain Tumor
PEV
position-effect variegation
HSPC
hematopoietic stem and progenitor cells
ChIP
chromatin immunoprecipitation
PK
pharmacokinetic
©版权所有 ©2017 CSpace - Powered by
CSpace